PURSGLOVE GEORDAN GARRETT (CEO and Chairman of the Board) received a stock award from LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2026ACC: 0001493152-26-031890
DirectorOfficer· CEO and Chairman of the Board
Since Jun 2025
+350K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
350K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+350K
Price / share
—
Trade value
—
% of position
100.0%
7/1/2026
350K→700K
Total
Net shares
+350K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | A · Award | +350K | — | — | 100.0% | 350K | 700K |
| Total | +350K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported